Ticker
QURECompany Name
UNIQURE NVSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 584.89M | $ 253.78M | 43.39% |
3/31/2025 | $ 605.4M | $ 217.23M | 35.88% |
12/31/2024 | $ 556.54M | $ 158.93M | 28.56% |
9/30/2024 | $ 645.81M | $ 251.63M | 38.96% |
6/30/2024 | $ 730.85M | $ 287.88M | 39.39% |
3/31/2024 | $ 770.05M | $ 243.06M | 31.56% |
12/31/2023 | $ 831.69M | $ 241.36M | 29.02% |
9/30/2023 | $ 871.55M | $ 229.48M | 26.33% |
6/30/2023 | $ 942.77M | $ 513.6M | 54.48% |
3/31/2023 | $ 631M | $ 153.85M | 24.38% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for UNIQURE NV is calculated as follows: CashnEq [ $ 279.49M ] / Assets [ $ 350.51M ]
(=) Cash to Assets [ 79.74% ]
Minimum
Mar 31, 2023
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.95K |
---|---|
min | 0% |
max | 40.92% |
average | 9.84% |
median | 6.44% |
std | 9.62% |